BHOC Therapeutics
BHOC Therapeutics develops Biological Hemoglobin Oxygen Carriers (BHOC): a cell-free form of hemoglobin designed to carry oxygen and release it where tissue needs it. Because it has no red-cell membrane and no blood-group antigens, it is designed to be compatible with all blood types. The company calls its approach Precision Oxygen Therapeutics, which means oxygen delivery that is controlled and predictable, down to the tissue and the cell.
The Technology
- Cell-free hemoglobin, with no red-cell antigens
- Engineered oxygen affinity for controlled loading and release
- Long shelf life targeted, for room-temperature handling
- Robust and portable for practical transport
What They Aim For
A complementary oxygen-delivery bridge, not a replacement for blood. Their research areas include organ transplantation, severe anemia, surgery and blood loss, cardiac and ischemic emergencies, sickle cell disease, emergency and remote care, and veterinary medicine.
Mission & Values
- Evidence before claims: every claim is linked to its scientific, clinical or regulatory source
- Honest framing: they don't call it “artificial blood”
- Life at every scale: protect life, preserve species, safeguard biodiversity
“One Oxygen. Every Species. One Living Planet.”
Visit BHOC Therapeutics at bhoctherapeutics.com →Opens bhoctherapeutics.com in a new tab. BHOC Therapeutics notes that these are areas of research and development, not approved therapeutic claims.